These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 10200559

  • 1. JNK/SAPK activity contributes to TRAIL-induced apoptosis.
    Herr I, Wilhelm D, Meyer E, Jeremias I, Angel P, Debatin KM.
    Cell Death Differ; 1999 Feb; 6(2):130-5. PubMed ID: 10200559
    [Abstract] [Full Text] [Related]

  • 2. NF-kappa B does not modulate sensitivity of renal carcinoma cells to TNF alpha-related apoptosis-inducing ligand (TRAIL).
    Pawlowski JE, Nesterov A, Scheinman RI, Johnson TR, Kraft AS.
    Anticancer Res; 2000 Feb; 20(6B):4243-55. PubMed ID: 11205254
    [Abstract] [Full Text] [Related]

  • 3. JNK/SAPK activity is not sufficient for anticancer therapy-induced apoptosis involving CD95-L, TRAIL and TNF-alpha.
    Herr I, Wilhelm D, Böhler T, Angel P, Debatin KM.
    Int J Cancer; 1999 Jan 29; 80(3):417-24. PubMed ID: 9935184
    [Abstract] [Full Text] [Related]

  • 4. Protective effects of estradiol on TRAIL-induced apoptosis in a human oligodendrocytic cell line: evidence for multiple sites of interactions.
    Cantarella G, Risuglia N, Lombardo G, Lempereur L, Nicoletti F, Memo M, Bernardini R.
    Cell Death Differ; 2004 May 29; 11(5):503-11. PubMed ID: 14739940
    [Abstract] [Full Text] [Related]

  • 5. Mechanisms of resistance to TRAIL-induced apoptosis in cancer.
    Zhang L, Fang B.
    Cancer Gene Ther; 2005 Mar 29; 12(3):228-37. PubMed ID: 15550937
    [Abstract] [Full Text] [Related]

  • 6. Autoamplification of apoptosis following ligation of CD95-L, TRAIL and TNF-alpha.
    Herr I, Posovszky C, Di Marzio LD, Cifone MG, Boehler T, Debatin KM.
    Oncogene; 2000 Aug 31; 19(37):4255-62. PubMed ID: 10980599
    [Abstract] [Full Text] [Related]

  • 7. C-jun N-terminal kinase activation is required for apoptotic cell death induced by TNF-related apoptosis-inducing ligand plus DNA-damaging agents in sarcoma cell lines.
    Mikami T, Koyama T, Koyama T, Imakiire A, Yamamoto K, Furuhata M, Toyota H, Mizuguchi J.
    Anticancer Res; 2006 Aug 31; 26(2A):1153-60. PubMed ID: 16619517
    [Abstract] [Full Text] [Related]

  • 8. JNK activation is not required for Fas-mediated apoptosis.
    Low W, Smith A, Ashworth A, Collins M.
    Oncogene; 1999 Jun 24; 18(25):3737-41. PubMed ID: 10391681
    [Abstract] [Full Text] [Related]

  • 9. TRAIL-induced death of human adult oligodendrocytes is mediated by JNK pathway.
    Jurewicz A, Matysiak M, Andrzejak S, Selmaj K.
    Glia; 2006 Jan 15; 53(2):158-66. PubMed ID: 16206163
    [Abstract] [Full Text] [Related]

  • 10. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
    Mitsiades N, Poulaki V, Tseleni-Balafouta S, Koutras DA, Stamenkovic I.
    Cancer Res; 2000 Aug 01; 60(15):4122-9. PubMed ID: 10945619
    [Abstract] [Full Text] [Related]

  • 11. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
    Izeradjene K, Douglas L, Delaney A, Houghton JA.
    Clin Cancer Res; 2004 Oct 01; 10(19):6650-60. PubMed ID: 15475455
    [Abstract] [Full Text] [Related]

  • 12. Regulation of TNF-related apoptosis-inducing ligand-mediated death-signal pathway in human beta cells by Fas-associated death domain and nuclear factor kappaB.
    Ou D, Wang X, Metzger DL, Robbins M, Huang J, Jobin C, Chantler JK, James RF, Pozzilli P, Tingle AJ.
    Hum Immunol; 2005 Jul 01; 66(7):799-809. PubMed ID: 16112027
    [Abstract] [Full Text] [Related]

  • 13. Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in androgen-independent prostate cancer cells.
    Yu R, Mandlekar S, Ruben S, Ni J, Kong AN.
    Cancer Res; 2000 May 01; 60(9):2384-9. PubMed ID: 10811114
    [Abstract] [Full Text] [Related]

  • 14. Antitumor agent parthenolide reverses resistance of breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through sustained activation of c-Jun N-terminal kinase.
    Nakshatri H, Rice SE, Bhat-Nakshatri P.
    Oncogene; 2004 Sep 23; 23(44):7330-44. PubMed ID: 15286701
    [Abstract] [Full Text] [Related]

  • 15. Alkyl-lysophospholipids activate the SAPK/JNK pathway and enhance radiation-induced apoptosis.
    Ruiter GA, Zerp SF, Bartelink H, van Blitterswijk WJ, Verheij M.
    Cancer Res; 1999 May 15; 59(10):2457-63. PubMed ID: 10344758
    [Abstract] [Full Text] [Related]

  • 16. Requirement of c-Jun NH2-terminal kinase activation in interferon-alpha-induced apoptosis through upregulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in Daudi B lymphoma cells.
    Yanase N, Hata K, Shimo K, Hayashida M, Evers BM, Mizuguchi J.
    Exp Cell Res; 2005 Oct 15; 310(1):10-21. PubMed ID: 16099454
    [Abstract] [Full Text] [Related]

  • 17. Signaling events triggered by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): caspase-8 is required for TRAIL-induced apoptosis.
    Seol DW, Li J, Seol MH, Park SY, Talanian RV, Billiar TR.
    Cancer Res; 2001 Feb 01; 61(3):1138-43. PubMed ID: 11221844
    [Abstract] [Full Text] [Related]

  • 18. Activation of protein kinase C inhibits TRAIL-induced caspases activation, mitochondrial events and apoptosis in a human leukemic T cell line.
    Sarker M, Ruiz-Ruiz C, López-Rivas A.
    Cell Death Differ; 2001 Feb 01; 8(2):172-81. PubMed ID: 11313719
    [Abstract] [Full Text] [Related]

  • 19. Murine TRAIL (TNF-related apoptosis inducing ligand) expression induced by T cell activation is blocked by rapamycin, cyclosporin A, and inhibitors of phosphatidylinositol 3-kinase, protein kinase C, and protein tyrosine kinases: evidence for TRAIL induction via the T cell receptor signaling pathway.
    Musgrave BL, Phu T, Butler JJ, Makrigiannis AP, Hoskin DW.
    Exp Cell Res; 1999 Oct 10; 252(1):96-103. PubMed ID: 10502402
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of CaMKII-mediated c-FLIP expression sensitizes malignant melanoma cells to TRAIL-induced apoptosis.
    Xiao C, Yang BF, Song JH, Schulman H, Li L, Hao C.
    Exp Cell Res; 2005 Mar 10; 304(1):244-55. PubMed ID: 15707589
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.